Vanguard Group
SSKN

Vanguard Group’s Strata Skin Sciences SSKN Stock Holding History

Vanguard Group’s Portfolio SSKN Stock Details SSKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$20.6K Sell
16,375
-7,170
-30% -$11.3K ﹤0.01% 4305
2025
Q3 		$48.5K Sell
23,545
-61,087
-72% -$121K ﹤0.01% 4300
2025
Q2 		$195K Hold
84,632
– – ﹤0.01% 4092
2025
Q1 		$223K Buy
84,632
+316
+0.4% +$880 ﹤0.01% 4048
2024
Q4 		$244K Hold
84,316
– – ﹤0.01% 4072
2024
Q3 		$232K Sell
84,316
-1,502
-2% -$4.69K ﹤0.01% 4113
2024
Q2 		$263K Sell
85,818
-2
-0% -$8 ﹤0.01% 4124
2024
Q1 		$324K Hold
85,820
– – ﹤0.01% 4102
2023
Q4 		$472K Hold
85,820
– – ﹤0.01% 4043
2023
Q3 		$511K Hold
85,820
– – ﹤0.01% 4047
2023
Q2 		$815K Hold
85,820
– – ﹤0.01% 3962
2023
Q1 		$909K Hold
85,820
– – ﹤0.01% 3952
2022
Q4 		$678K Hold
85,820
– – ﹤0.01% 4022
2022
Q3 		$747K Sell
85,820
-738
-0.9% -$7.49K ﹤0.01% 4089
2022
Q2 		$832K Hold
86,558
– – ﹤0.01% 4146
2022
Q1 		$1.27M Buy
86,558
+6,703
+8% +$100K ﹤0.01% 4135
2021
Q4 		$1.17M Sell
79,855
-106
-0.1% -$1.76K ﹤0.01% 4222
2021
Q3 		$1.47M Hold
79,961
– – ﹤0.01% 4152
2021
Q2 		$1.25M Buy
79,961
+6,005
+8% +$93.4K ﹤0.01% 4106
2021
Q1 		$1.24M Buy
73,956
+10,063
+16% +$183K ﹤0.01% 3967
2020
Q4 		$958K Sell
63,893
-22
-0% -$317 ﹤0.01% 3841
2020
Q3 		$863K Hold
63,915
– – ﹤0.01% 3688
2020
Q2 		$735K Hold
63,915
– – ﹤0.01% 3686
2020
Q1 		$607K Hold
63,915
– – ﹤0.01% 3631
2019
Q4 		$1.33M Hold
63,915
– – ﹤0.01% 3560
2019
Q3 		$1.36M Buy
63,915
+1,215
+2% +$28.5K ﹤0.01% 3563
2019
Q2 		$1.56M Buy
62,700
+2,100
+3% +$52.4K ﹤0.01% 3544
2019
Q1 		$1.73M Hold
60,600
– – ﹤0.01% 3498
2018
Q4 		$1.58M Buy
60,600
+1,264
+2% +$36.2K ﹤0.01% 3444
2018
Q3 		$2.1M Buy
59,336
+57,735
+3,606% +$1.42M ﹤0.01% 3508
2018
Q2 		$33K Hold
1,601
– – ﹤0.01% 4111
2018
Q1 		$18K Hold
1,601
– – ﹤0.01% 4091
2017
Q4 		$20K Sell
1,601
-266
-14% -$3.71K ﹤0.01% 4051
2017
Q3 		$33K Hold
1,867
– – ﹤0.01% 4041
2017
Q2 		$46K Buy
1,867
+715
+62% +$19.9K ﹤0.01% 4031
2017
Q1 		$35K Hold
1,152
– – ﹤0.01% 4044
2016
Q4 		$25K Sell
1,152
-11
-0.9% -$281 ﹤0.01% 4064
2016
Q3 		$30K Hold
1,163
– – ﹤0.01% 4059
2016
Q2 		$35K Buy
1,163
+86
+8% +$3.46K ﹤0.01% 4095
2016
Q1 		$51K Buy
1,077
+209
+24% +$10.8K ﹤0.01% 4076
2015
Q4 		$49K Hold
868
– – ﹤0.01% 4136
2015
Q3 		$50K Hold
868
– – ﹤0.01% 4138
2015
Q2 		$50K Buy
868
+389
+81% +$31.7K ﹤0.01% 4156
2015
Q1 		$61K Sell
479
-104
-18% -$10.3K ﹤0.01% 4112
2014
Q4 		$35K Sell
583
-908
-61% -$74.5K ﹤0.01% 4027
2014
Q3 		$129K Buy
1,491
+116
+8% +$13.6K ﹤0.01% 3935
2014
Q2 		$221K Hold
1,375
– – ﹤0.01% 3839
2014
Q1 		$428K Buy
1,375
+204
+17% +$71.8K ﹤0.01% 3693
2013
Q4 		$375K Sell
1,171
-539
-32% -$193K ﹤0.01% 3656
2013
Q3 		$619K Buy
1,710
+18
+1% +$7.2K ﹤0.01% 3497
2013
Q2 		$786K Buy
+1,692
New +$906K ﹤0.01% 3367

Other funds holding SSKN

2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group's SSKN Position: Q4 2025 in Review

Vanguard Group reduced its Strata Skin Sciences (SSKN) stake by 30% in Q4 2025, selling an estimated $11.3K and leaving 16,375 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4305.

Vanguard Group first reported a position in SSKN in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.1M in Q3 2018. 14 funds tracked by Wall St. Rank hold SSKN as of Q4 2025.

  • Vanguard Group held 16,375 shares of Strata Skin Sciences worth $20.6K as of Q4 2025.
  • Vanguard Group sold 7,170 Strata Skin Sciences shares in Q4 2025, an estimated $11.3K.
  • Strata Skin Sciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4305 holding.
  • Vanguard Group first reported a position in Strata Skin Sciences in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Strata Skin Sciences position peaked at $2.1M in Q3 2018.
  • 14 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.